SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 234.13 |
| Enterprise Value ($M) | 178.67 |
| Book Value ($M) | -45.53 |
| Book Value / Share | -0.82 |
| Price / Book | -5.14 |
| NCAV ($M) | -79.91 |
| NCAV / Share | -1.44 |
| Price / NCAV | -2.93 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.34 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.73 |
| Current Ratio | 3.73 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 249.60 |
| Assets | 283.98 |
| Liabilities | 329.51 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 22.60 |
| Operating Income | -100.28 |
| Net Income | -86.62 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -100.41 |
| Cash from Investing | -29.90 |
| Cash from Financing | 105.43 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Fmr Llc | 10.20 | -9.73 | |
| 13G/A | Klarman Family Foundation | 3.90 | ||
| 13G | Flynn James E | 5.31 | ||
| 13G | Biotechnology Value Fund L P | 9.99 | ||
| 13D/A | Flagship Ventures Fund V, L.P. | 22.90 | 28.64 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 23,964 | 85,316 | 28.09 | |
| 48,723 | 124,116 | 39.26 | |
| 32,271 | 149,963 | 21.52 | |
| 113,149 | 300,389 | 37.67 | |
| 26,741 | 110,330 | 24.24 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ETNB – 89bio, Inc. | ETON – Eton Pharmaceuticals, Inc. |
| FATE – Fate Therapeutics, Inc. | FOLD – Amicus Therapeutics, Inc. |
| FULC – Fulcrum Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io